Table 1.
Protocol | Training duration | ||
---|---|---|---|
2–4 weeks | 5–11 weeks | 12–16 weeks | |
Repeated Wingate SIT (3–8 × 30 s) | ↑ peak [44, 68, 70, 161] | ↑ peak [47, 54, 67] | ↑ peak [55] |
↓ HbA1c [162] ↔ HbA1c [55] |
↔ HbA1c [55] | ||
↑ CS protein content† [70] ↔ CS maximal activity† [163] ↔ COXIV protein content† [70] |
|||
HIIT (10–12 × 1 min) |
↔ peak [164] |
↑ peak [49, 50, 165] | ↑ peak [49] |
↔ OGTT insulin sensitivity [50] ↓ HOMA-IR [166] |
↓ HOMA-IR [110] | ||
↑ CS maximal activity [50] ↑ COX activity [121] |
|||
Repeated sprint SIT (6–20 s efforts) |
↑ peak [60, 167] | ↑ peak [51, 61, 63, 65, 66, 168] | |
↓ HOMA-IR [61] ↓ HbA1c [100] ↔ HbA1c [66] |
|||
Reduced-volume SIT (≤ 10 min session) |
↔ peak [75] |
↑ peak [52, 53, 69, 71, 75] | ↑ peak [10, 75] |
↔ OGTT insulin sensitivity [69, 71] ↔ 24 h glucose mean or AUC [53] ↓ HOMA-IR† [53] |
↔ HOMA-IR† [10] | ||
↑ CS maximal activity† [53] ↑ COXIV protein content† [53] |
|||
Reduced-volume HIIT (5 × 1 min) | ↑ peak [73, 76] | ||
↔ OGTT glucose and insulin AUC [73] ↓ HOMA-IR [76] ↔ HbA1c [73] |
|||
↑ mitochondrial complex I, II, III, IV and V protein content† [138] ↑ CS maximal activity† [138] |
Studies were conducted in women who were classified as healthy [10, 46, 47, 49, 52, 54, 65, 69–72, 75, 79, 161], with overweight/obesity [44, 50, 51, 53, 55, 60–63, 66, 67, 73, 76, 100, 110, 121, 138, 162, 164, 167, 168] and/or type 2 diabetes [100, 162]. For transparency, the same cohort of women was examined in the following pairs of references: [50, 121] and [73, 138]. The symbol (†) denotes when a finding has only been documented in a study comparing responses between sexes and is based on a main effect of time for both men and women. Abbreviations: ↑ increase; ↓ decrease; ↔ no change; AUC area under the curve; COXIV cytochrome c oxidase subunit IV; CS citrate synthase; HbA1c glycated hemoglobin; HOMA-IR homeostatic model assessment of insulin resistance; OGTT oral glucose tolerance test; peak peak oxygen uptake